National Stock Exchange of India Limited makes a corporate announcement

The specific content of disclosure SEC/1009/2026 dated September 10, 2026 could not be confirmed from the cited material.

On the evidence available, it should not be classified as a change in NSE’s core trading infrastructure. The trading-technology material describes NSE’s existing platforms, network and co-location facilities, rather than a September 10 change announcement ^[1].

The closest relevant item is a regulatory-compliance framework for safer retail participation in algorithmic trading, including empanelment of algo providers and evaluation of their background, infrastructure and systems ^[2]. Therefore, if SEC/1009/2026 refers to that item, its nature is a compliance or supervisory-framework change—not a redesign of the exchange’s trading infrastructure. The supplied evidence does not directly establish that this framework update is the disclosure dated September 10.

The September 17, 2026 filing bearing Ref. No. AAVAS/SEC/2026-27/3198 could not be confirmed, so the specific development and its full conditions precedent cannot be stated reliably.

If the reference relates to Aavas’s insurance-distribution initiative, the subsequent regulatory filing identifies the following requirements:

• IRDAI Certificate of Registration: Aavas required a Certificate of Registration from the Insurance Regulatory and Development Authority of India to act as a Corporate Agent under the Insurance Act, 1938. The company reported receiving this approval on October 26, 2026, under Regulations 9 and 11 of the IRDAI (Registration of Corporate Agents) Regulations, 2015. ^{[3] [4]}
• Effective date: The approval became effective on December 8, 2026; therefore, the corporate-agent activity could be operationalized from that date rather than merely upon announcement of the initiative. ^{[3] [4]}
• Ongoing conditions: The registration is perpetual only subject to payment of the prescribed annual fee and continued compliance with applicable regulatory requirements. ^{[3] [4]}
• Permitted activity: The approval enables Aavas to solicit insurance products for its customers as a corporate agent. ^[4]

No additional approval, implementation milestone, or separate condition precedent tied specifically to Ref. No. AAVAS/SEC/2026-27/3198 could be confirmed. The later filing does not establish whether any other consent—such as product-level, partner-level, or operational approval—was required.

_Scope note: this comparison also included National Stock Exchange of India Limited (NSE), which the answer above does not cover. Ask about any of them for a full side-by-side._